A panoramic, practice-based view of intravenous alteplase 3-4.5 h after stroke

被引:0
|
作者
Kasner, Scott E. [1 ,2 ]
Levine, Steven R. [3 ,4 ,5 ]
机构
[1] Univ Penn, Med Ctr, Stroke Ctr, Philadelphia, PA 19104 USA
[2] Univ Penn, Med Ctr, Dept Neurol, Philadelphia, PA 19104 USA
[3] SUNY Hlth Sci Ctr, Stroke Ctr, Brooklyn, NY 11203 USA
[4] SUNY Hlth Sci Ctr, Dept Neurol, Brooklyn, NY 11203 USA
[5] Sch Med, Brooklyn, NY 11203 USA
来源
LANCET NEUROLOGY | 2010年 / 9卷 / 09期
关键词
ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN ACTIVATOR; THROMBOLYSIS; TIME;
D O I
10.1016/S1474-4422(10)70169-1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:843 / 845
页数:3
相关论文
共 50 条
  • [41] Intravenous recombinant tissue plasminogen activator administered after 3 h following onset of ischaemic stroke: a metaanalysis
    Maiser, Samuel J.
    Georgiadis, Alexandros L.
    Suri, M. Fareed K.
    Vazquez, Gabriela
    Lakshminarayan, Kamakshi
    Qureshi, Adnan I.
    INTERNATIONAL JOURNAL OF STROKE, 2011, 6 (01) : 25 - 32
  • [42] Thrombolysis with Low-Dose Tissue Plasminogen Activator 3–4.5 h After Acute Ischemic Stroke in Five Hospital Groups in Japan
    Ryuta Morihara
    Syoichiro Kono
    Kota Sato
    Nozomi Hishikawa
    Yasuyuki Ohta
    Toru Yamashita
    Kentaro Deguchi
    Yasuhiro Manabe
    Yoshiki Takao
    Kenichi Kashihara
    Satoshi Inoue
    Hideki Kiriyama
    Koji Abe
    Translational Stroke Research, 2016, 7 : 111 - 119
  • [43] Association between brain imaging signs, early and late outcomes, and response to intravenous alteplase after acute ischaemic stroke in the third International Stroke Trial (IST-3): secondary analysis of a randomised controlled trial
    Wardlaw, Joanna M.
    Sandercock, Peter
    Cohen, Geoff
    Farrall, Andrew
    Lindley, Richard I.
    von Kummer, Rudiger
    von Heijne, Anders
    Bradey, Nick
    Peeters, Andre
    Cala, Lesley
    Adami, Alessandro
    Morris, Zoe
    Potter, Gillian
    Murray, Gordon
    Whiteley, Will
    Perry, David
    Sakka, Eleni
    LANCET NEUROLOGY, 2015, 14 (05): : 485 - 496
  • [44] 3-year Outcome of Patients with Persistent Pain after Root Canal Treatment: The National Dental Practice-Based Research Network
    Daline, Iryna H.
    Nixdorf, Donald R.
    Law, Alan S.
    Pileggi, Roberta
    JOURNAL OF ENDODONTICS, 2020, 46 (05) : 619 - +
  • [45] Non-immunogenic recombinant staphylokinase versus alteplase for patients with acute ischaemic stroke 4.5 h after symptom onset in Russia (FRIDA): a randomised, open label, multicentre, parallel-group, non-inferiority trial
    Gusev, Eugene, I
    Martynov, Mikhail Yu
    Nikonov, Alexey A.
    Shamalov, Nikolay A.
    Semenov, Michail P.
    Gerasimets, Eugene A.
    Yarovaya, Elena B.
    Semenov, Andrey M.
    Archakov, Alexander, I
    Markin, Sergey S.
    LANCET NEUROLOGY, 2021, 20 (09): : 721 - 728
  • [46] Addressing a real-life problem: treatment with intravenous thrombolysis and mechanical thrombectomy in acute stroke patients with an extended time window beyond 4.5 h based on computed tomography perfusion imaging
    Feil, K.
    Reidler, P.
    Kunz, W. G.
    Kuepper, C.
    Heinrich, J.
    Laub, C.
    Mueller, K.
    Voeglein, J.
    Liebig, T.
    Dieterich, M.
    Kellert, L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 (01) : 168 - 174
  • [47] Early neurological deterioration in acute ischemic stroke patients after intravenous thrombolysis with alteplase predicts poor 3-month functional prognosis-data from the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China)
    Che, Fengli
    Wang, Anxin
    Ju, Yi
    Ding, Yarong
    Duan, Honglian
    Geng, Xiaokun
    Zhao, Xingquan
    Wang, Yongjun
    BMC NEUROLOGY, 2022, 22 (01)
  • [48] Correction: Early neurological deterioration in acute ischemic stroke patients after intravenous thrombolysis with alteplase predicts poor 3-month functional prognosis - data from the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China)
    Fengli Che
    Anxin Wang
    Yi Ju
    Yarong Ding
    Honglian Duan
    Xiaokun Geng
    Xingquan Zhao
    Yongjun Wang
    BMC Neurology, 22
  • [49] Combined Intravenous and Intraarterial Revascularization Therapy Using MRI Perfusion/Diffusion Mismatch Selection for Acute Ischemic Stroke at 3–6 h After Symptom Onset
    Moon-Ku Han
    Sung Hyun Kim
    Sang-Bae Ko
    Nam-Jong Paik
    O-Ki Kwon
    Yong-Seok Lee
    Chang-Wan Oh
    Jae Hyoung Kim
    Seong-Ho Park
    Hee-Joon Bae
    Neurocritical Care, 2008, 8 : 353 - 359
  • [50] Combined intravenous and intraarterial revascularization therapy using MRI Perfusion/Diffusion mismatch selection for acute ischemic stroke at 3-6 h after symptom onset
    Han, Moon-Ku
    Kim, Sung Hyun
    Ko, Sang-Bae
    Paik, Nam-Jong
    Kwon, O-Ki
    Lee, Yong-Seok
    Oh, Chang-Wan
    Kim, Jae Hyoung
    Park, Seong-Ho
    Bae, Hee-Joon
    NEUROCRITICAL CARE, 2008, 8 (03) : 353 - 359